Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Century Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Investor presentation
Docs: "Corporate Overview Aug 2023"
08/09/2023 8-K Investor presentation, Quarterly results
Docs: "Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates",
"Investor Presentation of Century Therapeutics, Inc."
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/29/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 8-K Quarterly results
Docs: "Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 8-K/A Quarterly results
05/05/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/23/2023 144 Form 144 - Report of proposed sale of securities:
03/22/2023 144 Form 144 - Report of proposed sale of securities:
03/21/2023 144 Form 144 - Report of proposed sale of securities:
03/20/2023 8-K Quarterly results
03/17/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/16/2023 8-K Quarterly results
Docs: "Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates"
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/09/2023 SC 13G/A Versant Venture Capital VI, L.P. reports a 19.4% stake in Century Therapeutics, Inc.
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2023 8-K Investor presentation
Docs: "Investor Presentation of Century Therapeutics, Inc.",
"Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026"
11/30/2022 8-K Quarterly results
10/11/2022 SC 13D/A Casdin Capital, LLC reports a 5.5% stake in Century Therapeutics, Inc.
10/03/2022 8-K Quarterly results
09/08/2022 8-K Quarterly results
08/25/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/14/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/01/2022 8-K Quarterly results
07/01/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/13/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy